Compounds and methods for treating candidiasis and aspergillus infections

US8895561B2 · kind B2 · utility

Assignees

• Cellceutix Corporation · US
• Rutgers, the State University of New Jersey · US

Inventors

• Richard W. Scott · West Chester, US
• Katie Freeman · Radnor, US
• Haizhong Tang · Lawrenceville, US
• Gill Diamond · Philadelphia, US

Key dates

• Filing date: Jan 18, 2013
• Grant date: Nov 25, 2014
• Expiry date: Jan 18, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D409/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure provides compounds, or pharmaceutically acceptable salts thereof, for killing or inhibiting the growth of a Candida or Aspergillus species or preventing or treating a mammal having candidiasis (oral and/or disseminated) or an Aspergillus infection.